Stempeutics is a leading Regenerative Medicine company in Bangalore with our patented stem-cell therapy platform technology developing treatment of cardiovascular, immune-mediated and degenerative diseases.
The company's flagship product, Stempeucel® has received market authorization to treat Critical Limb Ischemia – a major unmet medical need in India. It is the FIRST innovative cell therapy based product to get marketing approval in India and Globally. CIPLA, the Indian licensee, has commenced pan-India commercialization.
It has the FIRST DCGI approved Cell therapy product for Knee Osteoarthritis being marketed by Alkem. Stempeutics has a product in the Phase 3 stage covering Diabetic Foot Ulcer. Further it is conducting Phase 2 trial in Perianal fistula due to Crohn’s disease. Stempeucel® has strong patent protection with 20 patents granted including US, Europe and Japan. Stempeucel® has been classified as an Advanced Therapy Medicinal Product (ATMP) and designated as an Orphan Drug for the treatment of CLI due to Buerger’s Disease by the European Medicines Agency (EMA)
Another portfolio developed by Stempeutics is Stempeucare® range of cosmetics. It is developed from the stem cell derived Growth Factors/Cytokines combination for various cosmetic and derma applications including rejuvenation of aging skin, hair fall control & hair growth promotion, under eye dark circle reduction cream etc. First product which has gone to the market is an intensive firming skin care cosmetic product, branded as Cutisera™. Other products ready for marketing are Trichosera™ for Hair application and Optisera™ for under eye application
With a strong pipeline in Cell and Gene therapy products in some of the largest health and personal care segments like OTC Cosmetics (Skin and Hair Care), Osteoarthritis, Diabetes, CLI and PAF Stempeutics is poised to transform the Cell & Gene therapy space with its India First, Global Next approach.
Company Details
- Employees
- 61
- Founded
- -
- Address
- 3rd Floor, Manipal Hospitals Whitefield #143, Epip Industrial Area,itpl Main Road,whitefield,india
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.stempeutics.com/
- HQ
- Bangalore, Karnataka
Stempeutics Research Private Limited Questions
Stempeutics Research Private Limited's website is https://www.stempeutics.com/
Stempeutics Research Private Limited's LinkedIn profile is https://in.linkedin.com/company/stempeutics-research-private-limited
Stempeutics Research Private Limited has
61 employees.
View email and phone details for 61
employees at Stempeutics Research Private Limited.
Stempeutics Research Private Limited's industry is
Biotechnology Research
Stempeutics Research Private Limited's top competitors are
Strand Life Sciences,
String Bio Private Limited,
Eyestem Research,
Kemwell Biopharma,
Medgenome,
Immuneel Therapeutics Pvt. Ltd.,
Bugworks Research Inc.,
Stemcyte India Therapeutics Pvt. Ltd.,
Pandorum Technologies,
Aurigene Oncology Limited.
Stempeutics Research Private Limited's categories are Biotechnology Research
Stempeutics Research Private Limited's founding year is 2006
